New Times,
New Thinking.

  1. Business
  2. Economics
1 July 2015

Greece misses its IMF €1.5bn payment deadline as its bailout expires

Greece has missed the deadline to pay €1.5bn to the International Monetary Fund, putting the country into arrears, while eurozone ministers refuse to extend its bailout.

By New Statesman

The Greek government has missed the deadline for its latest €1.5bn ($1.1bn) payment to the International Monetary Fund IMF). 

An IMF spokesperson said: “I confirm that the SDR 1.2 billion repayment (about EUR 1.5 billion) due by Greece to the IMF today has not been received. We have informed our Executive Board that Greece is now in arrears and can only receive IMF financing once the arrears are cleared.”

Greece has become the first developed country in the IMF’s 71-year history to miss a payment to the body. The missed payment is not being treated as a “credit event” by Greece’s creditors, staving off a default for now, although the pressure on Greek’s shuttered banks will continue. The development is a further blow to Alex Tspiras’ hopes of securing a No vote in the forthcoming referendum on the now-expired bailout package.

UPDATE: 10am 1/7/15

The ministers say they will discuss an 11th-hour request from the Greek government for a new two-year extension of the payment deadline. An IMF spokesperson said it would go to the board and be discussed “in due course”. But German chancellor Angela Merkel insists that nothing will be considered until after Sunday’s referendum on creditors’ bailout terms.

Select and enter your email address Your weekly guide to the best writing on ideas, politics, books and culture every Saturday. The best way to sign up for The Saturday Read is via saturdayread.substack.com The New Statesman's quick and essential guide to the news and politics of the day. The best way to sign up for Morning Call is via morningcall.substack.com
Visit our privacy Policy for more information about our services, how Progressive Media Investments may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications.
THANK YOU

Content from our partners
Unlocking investment in UK life sciences through manufacturing
Data defines a new era for fundraising
A prescription for success: improving the UK's access to new medicines